Viewing Study NCT02399956


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-01-01 @ 2:27 PM
Study NCT ID: NCT02399956
Status: COMPLETED
Last Update Posted: 2015-12-10
First Post: 2015-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lactation Outcomes Among Survivors of Pediatric Cancer
Sponsor: St. Jude Children's Research Hospital
Organization:

Study Overview

Official Title: Lactation Outcomes Among Survivors of Pediatric Cancer
Status: COMPLETED
Status Verified Date: 2015-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: While the majority of women in the general population can breastfeed successfully, the investigators have limited knowledge about the correlates and sequelae of lactation success among women treated for pediatric malignancies. Childhood cancer treatments are known to cause late effects that frequently involve the endocrine system. Because normal lactation is dependent upon interplay of multiple endocrine factors, the investigators anticipate more breastfeeding difficulties in survivors that have diabetes, growth hormone deficiencies, thyroid disorders and obesity. In order to more fully inform clinicians and female survivors, the study of the burden of lactation failure is needed to begin to address the impact of pediatric cancer therapy on lactation success/failure and to examine the association of specific endocrine disorders on lactation outcomes.
Detailed Description: Participants will complete a cross-sectional survey. Responses will be compared with a national sample of healthy women from Project First (Infant Feeding Practices Survey II).

Primary Objective:

* To describe breastfeeding outcomes (intention, initiation, duration, and weaning) among female SJLIFE protocol participants 18 years of age and older who reported a live birth.

Secondary Objective:

* To compare breastfeeding outcomes between childhood cancer survivors and healthy mothers.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: